Back to the main directory
Press Release
- Entrada Therapeutics Announces FDA Removal of Clinical Hold on ENTR-601-44 by GlobeNewsWire
- Apollo Silver Further Strengthens Board of Directors by GlobeNewsWire
- Monte Rosa Therapeutics to Present at the TD Cowen 45th Annual Health Care Conference by GlobeNewsWire
- Skye Bioscience to Participate in SXSW Session on Obesity by GlobeNewsWire
- Axsome Therapeutics Announces SYMBRAVO® (meloxicam and rizatriptan) Achieves Primary Endpoint in the EMERGE Phase 3 Trial in Migraine Patients Experiencing Inadequate Response to Oral CGRP Inhibitors by GlobeNewsWire
- Allegro MicroSystems Appoints Mike Doogue as President and Chief Executive Officer by GlobeNewsWire
- Kaspi.kz 4Q and FY 2024 Financial Results by GlobeNewsWire
- FDA Declined Invivyd’s Request to Expand Existing Emergency Use Authorization of PEMGARDA™ (pemivibart) to Include Treatment of Mild-to-Moderate COVID-19 For Immunocompromised Persons Who Have No Alternative Therapeutic Options; No Change to the Existing by GlobeNewsWire
- Volaris Reports Financial Results for the Fourth Quarter 2024: Net Income of $46 million by GlobeNewsWire
- Allied Announces Renewal of Normal Course Issuer Bid by GlobeNewsWire
- Aktietilbagekøb i Djurslands Bank - transaktioner i uge 8 by GlobeNewsWire
- Werewolf Therapeutics Appoints Anil Singhal, Ph.D., to its Board of Directors by GlobeNewsWire
- Houston American Energy Corp. Enters Definitive Agreement to Acquire Abundia Global Impact Group, Expanding into Renewable Fuels and Chemicals by GlobeNewsWire
- Red Cat Holdings Proud to Announce Teal’s Black Widow™ and FlightWave’s Edge 130 Selected as Winners of the Blue UAS Refresh by GlobeNewsWire
- EuroDry Ltd. Reports Results for the Year and Quarter Ended December 31, 2024 by GlobeNewsWire
- Kaldvik AS (KLDVK): Q4 2024 Webcast results 26 February 2025 at 11:00 (CET) by GlobeNewsWire
- Alvotech to Report Full Year Financial Results for 2024 on March 26, 2025, and Hosts Conference Call on March 27, 2025, at 8:00 am ET by GlobeNewsWire
- ASML reports transactions under its current share buyback program by GlobeNewsWire
- STMicroelectronics Announces Status of Common Share Repurchase Program by GlobeNewsWire
- Prime Medicine to Present at TD Cowen 45th Annual Health Care Conference by GlobeNewsWire
- MISSION PRODUCE® to Release Fiscal First Quarter 2025 Financial Results on Monday, March 10, 2025 by GlobeNewsWire
- LENZ Therapeutics to Participate in Upcoming Investor Conferences by GlobeNewsWire
- Phathom Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Business Update on Thursday, March 6, 2025 by GlobeNewsWire
- Douglas Dynamics Appoints New President of Work Truck Attachments by GlobeNewsWire
- reAlpha Acquires GTG Financial, Inc. by GlobeNewsWire